Imaging in sepsis-associated encephalopathy - Insights and opportunities

Nature Reviews Neurology

Volumn 9, Issue 10, 2013, Pages 551-561

  Stubbs, Daniel J ^a   Yamamoto, Adam K ^b   Menon, David K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; NEUROTRANSMITTER;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN METABOLISM; BRAIN NERVE CELL; BRAIN PERFUSION; CELL ACTIVATION; CELL FUNCTION; CELL LOSS; CELL MIGRATION; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS; CYTOKINE PRODUCTION; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FLUID ATTENUATED INVERSION RECOVERY IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; IMAGING AND DISPLAY; INFLAMMATORY CELL; ISCHEMIA; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEUROIMAGING; NONHUMAN; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; SENSITIVITY ANALYSIS; SEPSIS ASSOCIATED ENCEPHALOPATHY;

BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES; ENDOTHELIAL CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; SEPSIS;

EID: 84885641378     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2013.177     Document Type: Article

References (103)

1. Iwashyna, T. J., Ely, E. W., Smith, D. M. & Langa, K. M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304, 1787-1794 (2010).
2. Iacobone, E. et al. Sepsis-associated encephalopathy and its differential diagnosis. Crit. Care Med. 37, S331-S336 (2009).
3. Piazza, O., Russo, E., Cotena, S., Esposito, G. & Tufano, R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br. J. Anaesth. 99, 518-521 (2007).
4. Piazza, O., Cotena, S., De Robertis, E., Caranci, F. & Tufano, R. Sepsis associated encephalopathy studied by MRI and cerebral spinal fluid S100B measurement. Neurochem. Res. 34, 1289-1292 (2009).
5. Young, G. B., Bolton, C. F., Archibald, Y. M., Austin, T. W. & Wells, G. A. The electroencephalogram in sepsis-associated encephalopathy. J. Clin. Neurophysiol. 9, 145-152 (1992).
6. Zauner, C. et al. Impaired subcortical and cortical sensory evoked potential pathways in septic patients. Crit. Care Med. 30, 1136-1139 (2002).
7. Siami, S., Annane, D. & Sharshar, T. The encephalopathy in sepsis. Crit. Care Clin. 24, 67-82 (2008).
8. Taccone, F. S. et al. Cerebral microcirculation is impaired during sepsis: An experimental study. Crit. Care 14, R140 (2010).
9. Taccone, F. S. et al. Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit. Care 12, 35-42 (2010).
10. Sprung, C. L. et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit. Care Med. 18, 801-806 (1990).
11. Morandi, A. et al. The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: The VISIONS prospective cohort magnetic resonance imaging study. Crit. Care Med. 40, 2182-2189 (2012).
12. Gunther, M. L. et al. The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: The VISIONS cohort magnetic resonance imaging study. Crit. Care Med. 40, 2022-2032 (2012).
13. Luitse, M. J., Van Asch, C. J.. & Klijn, C. J. Deep coma and diffuse white matter abnormalities caused by sepsis-associated encephalopathy. Lancet 381, 2222 (2013).
14. Gofton, T. E. & Young, G. B. Sepsis-associated encephalopathy. Nat. Rev. Neurol. 8, 557-566 (2012).
15. Abe, S. et al. Sepsis associated encephalopathy in an infant with biliary atresia. Brain Dev. 30, 544-547 (2008).
16. Bartynski, W. S., Boardman, J. F., Zeigler, Z. R., Shadduck, R. K. & Lister, J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am. J. Neuroradiol. 27, 2179-2190 (2006).
17. Waydhas, C. Intrahospital transport of critically ill patients. Crit. Care 3, R83-R89 (1999).
18. Peden, C. J., Menon, D. K., Hall, A. S., Sargentoni, J. & Whitwam, J. G. Magnetic resonance for the anaesthetist. Part II: Anaesthesia and monitoring in MR units. Anaesthesia 47, 508-517 (1992).
19. Kondo, A. et al. Fulminant sepsis-associated encephalopathy in two children: Serial neuroimaging findings and clinical course. Neuropediatrics 40, 157-161 (2009).
20. Höllinger, P., Zürcher, R., Schroth, G. & Mattle, H. P. Diffusion magnetic resonance imaging findings in cerebritis and brain abscesses in a patient with septic encephalopathy. J. Neurol. 247, 232-234 (2000).
21. Jackson, A. C., Gilbert, J. J., Young, G. B. & Bolton, C. F. The encephalopathy of sepsis. Can. J. Neurol. Sci. 12, 303-307 (1985).
22. Gupta, R. K. et al. In vivo demonstration of neuroinflammatory molecule expression in brain abscess with diffusion tensor imaging. AJNR Am. J. Neuroradiol. 29, 326-332 (2008).
23. Vernooij, M. W. et al. Incidental findings on brain MRI in the general population. N. Engl. J. Med. 357, 1821-1828 (2007).
24. Suchyta, M. R., Jephson, A. & Hopkins, R. O. Neurologic changes during critical illness: Brain imaging findings and neurobehavioral outcomes. Brain Imaging Behav. 4, 22-34 (2010).
25. Schellinger, P. D. et al. Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 75, 177-185 (2010).
26. Morgenstern, L. B. et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41, 2108-2129 (2010).
27. Britt, R. H. & Enzmann, D. R. Clinical stages of human brain abscesses on serial CT scans after contrast infusion. Computerized tomographic, neuropathological, and clinical correlations. J. Neurosurg. 59, 972-989 (1983).
28. Chang, S. C. et al. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: Comparison with conventional MRI. Clin. Imaging 26, 227-236 (2002).
29. Sharshar, T. et al. Brain lesions in septic shock: A magnetic resonance imaging study. Intensive Care Med. 33, 798-806 (2007).
30. Finelli, P. F. & Uphoff, D. F. Magnetic resonance imaging abnormalities with septic encephalopathy. J. Neurol. Neurosurg. Psychiatry 75, 1189-1191. 2004
31. Fugate, J. E. et al. Posterior reversible encephalopathy syndrome: Associated clinical and radiologic findings. Mayo Clin. Proc. 85, 427-432 (2010).
32. Aridon, P. et al. Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura. Neurol. Sci. 32, 469-472 (2011).
33. Booth, K. K., Terrell, D. R., Vesely, S. K. & George, J. N. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am. J. Hematol. 86, 743-751 (2011).
34. Smith, D. B. & Gulinson, J. Fatal cerebral edema complicating toxic shock syndrome. Neurosurgery 22, 598-599 (1988).
35. Moss, R. F., Parmar, N. K., Tighe, D. & Davies, D. C. Adrenergic agents modify cerebral edema and microvessel ultrastructure in porcine sepsis. Crit. Care Med. 32, 1916-1921 (2004).
36. Morandi, A. et al. Neuroimaging in delirious intensive care unit patients: A preliminary case series report. Psychiatry 7, 28-33 (2010).
37. Jackson, J. C. et al. Acute respiratory distress syndrome, sepsis, and cognitive decline: A review and case study. South. Med. J. 102, 1150-1157 (2009).
38. Semmler, A. et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J. Neurol. Neurosurg. Psychiatry 84, 62-69 (2013).
39. Chavan, S. S. et al. HMGB1 mediates cognitive impairment in sepsis survivors. Mol. Med. 18, 930-937 (2012).
40. Mueller, S., Keeser, D., Reiser, M. F. Teipel, S. & Meindl, T. Functional and structural MR imaging in neuropsychiatric disorders, Part 1: Imaging techniques and their application in mild cognitive impairment and alzheimer disease. AJNR Am. J. Neuroradiol. 33, 1845-1850 (2012).
41. Teipel, S. J. et al. Multivariate deformation-based analysis of brain atrophy to predict alzheimer?s disease in mild cognitive impairment. NeuroImage 38, 13-24 (2007).
42. Weiner, M. W. et al. The alzheimer?s Disease Neuroimaging Initiative: A review of papers published since its inception. alzheimers Dement. 8, S1-S68 (2012).
43. Salmond, C. H., Chatfield, D. A., Menon, D. K., Pickard, J. D. & Sahakian, B. J. Cognitive sequelae of head injury: Involvement of basal forebrain and associated structures. Brain 128, 189-200 (2005).
44. Soeda, A. et al. Cognitive impairment after traumatic brain injury: A functional magnetic resonance imaging study using the Stroop task. Neuroradiology 47, 501-506 (2005).
45. Sharshar, T., Polito, A., Checinski, A. & Stevens, R. D. Septic-associated encephalopathy-everything starts at a microlevel. Crit. Care 14, 199 (2010).
46. Serres, S. et al. VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis. FASEB J. 12, 4415-4422 (2011).
47. Hofer, S. et al. Injury of the blood brain barrier and up-regulation of ICAM-1 in polymicrobial sepsis. J. Surg. Res. 146, 276-281 (2008).
48. Handa, O., Stephen, J. & Cepinskas, G. Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am. J. Physiol. Heart Circ. Physiol. 295, H1712-H1719 (2008).
49. Weberpals, M. et al. NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J. Neurosci. 29, 14177-14184 (2009).
50. Sharshar, T. et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362, 1799-1805 (2003).
51. Fujii, H. et al. Measuring brain tissue oxygenation under oxidative stress by ESR/MR dual imaging system. Magn. Reson. Med. Sci. 6, 83-89 (2007).
52. Tsao, N., Hsu, H. P., Wu, C. M., Liu, C. C. & Lei, H. Y. Tumour necrosis factor-α causes an increase in blood-brain barrier permeability during sepsis. J. Med. Microbiol. 50, 812-821 (2001).
53. Bogdanski, R. et al. Cerebral histopathology following portal venous infusion of bacteria in a chronic porcine model. Anesthesiology 93, 793-804 (2000).
54. Argaw, A. T. et al. IL-1 β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 177, 5574-5584 (2006).
55. Bozza, F. A. et al. Sepsis-associated encephalopathy: A magnetic resonance imaging and spectroscopy study. J. Cereb. Blood Flow Metab. 30, 440-448 (2010).
56. Rosengarten, B. et al. LPS-induced endotoxic shock does not cause early brain edema formation-an MRI study in rats. Inflamm. Res. 57, 479-483 (2008).
57. Bay-Richter, C., Janelidze, S., Hallberg, L. & Brundin, L. Changes in behaviour and cytokine expression upon a peripheral immune challenge. Behav. Brain Res. 222, 193-199 (2011).
58. Bendszus, M. et al. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: A quantitative MRI study. Brain 131, 2341-2352 (2008).
59. Stoll, G. et al. Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging. J. Cereb. Blood Flow Metab. 29, 331-341 (2009).
60. Wuerfel, E., Infante-Duarte, C., Glumm, R. & Wuerfel, J. T. Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation. J. Neuroinflammation 7, 70 (2010).
61. Irwan, Y. Y. et al. Quantitative analysis of cytokine-induced vascular toxicity and vascular leak in the mouse brain. J. Immunol. Methods 349, 45-55 (2009).
62. Hellman, R. N. Gadolinium-induced nephrogenic systemic fibrosis. Semin. Nephrol. 31, 310-316 (2011).
63. Kümpers, P. et al. The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit. Care 15, R261 (2011).
64. Su, G. et al. Blockade of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. Am. J. Resp. Crit. Care Med. 185, 1-49 (2011).
65. Zannetti, A. et al. Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with αvβ5. Clin. Cancer Res. 15, 5224-5233 (2009).
66. Flögel, U. et al. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118, 140-148 (2008).
67. Vellinga, M. M. et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131, 800-807 (2008).
68. Cho, T.-H. et al. USPIO-enhanced MRI of neuroinflammation at the sub-acute stage of ischemic stroke: Preliminary data. Cerebrovasc. Dis. 24, 544-546 (2007).
69. Nighoghossian, N. et al. Inflammatory response after ischemic stroke: A USPIO-enhanced MRI study in patients. Stroke 38, 303-307 (2007).
70. Schipper, H. M. Neurodegeneration with brain iron accumulation-clinical syndromes and neuroimaging. Biochim. Biophys. Acta 1822, 350-360 (2012).
71. Price, C. J. et al. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: An imaging-based study. Stroke 35, 1659-1664 (2004).
72. Jenkinson, M. D. et al. Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J. Magn. Reson. Imaging 26, 1405-1412 (2007).
73. Jenkinson, M. D. et al. Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype. J. Neurooncol. 96, 385-392 (2010).
74. Yamashita, Y., Kumabe, T., Higano, S., Watanabe, M. & Tominaga, T. Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas. Neurol. Res. 31, 940-946 (2009).
75. Wang, Y. et al. Quantification of increased cellularity during inflammatory demyelination. Brain 134, 3587-3598 (2011).
76. Lemstra, A. W. et al. Microglia activation in sepsis: A case-control study. J. Neuroinflammation 4, 4 (2007).
77. Kacimi, R., Giffard, R. G. & Yenari, M. A. Endotoxin-activated microglia injure brain derived endothelial cells via NF-kB, JAK-STAT and JNK stress kinase pathways. J. Inflamm. (Lond.) 8, 7 (2011).
78. Hughes, J. L. et al. A microPET study of the regional distribution of [11C]-PK11195 binding following temporary focal cerebral ischemia in the rat. Correlation with post mortem mapping of microglia activation. NeuroImage 59, 2007-2016 (2012).
79. Doorduin, J. et al. [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: A comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis. Mol. Imaging Biol. 11, 386-398 (2009).
80. Vas, A. et al. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. J. Neurol. Sci. 264, 9-17 (2008).
81. Signoretti, S. et al. N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J. Neurotrauma 18, 977-991 (2001).
82. Semmler, A. et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J. Neuroinflammation 5, 38 (2008).
83. Rosengarten, B. et al. Microcirculatory dysfunction in the brain precedes changes in evoked potentials in endotoxin-induced sepsis syndrome in rats. Cerebrovasc. Dis. 23, 140-147 (2007).
84. Hotchkiss, R. S. et al. An in vivo examination of rat brain during sepsis with 31P-NMR spectroscopy. Am. J. Physiol. 257, C1055-C1061 (1989).
85. Freund, H. R., Muggia-Sullam, M., Peiser, J. & Melamed, E. Brain neurotransmitter profile is deranged during sepsis and septic encephalopathy in the rat. J. Surg. Res. 38, 267-271 (1985).
86. Girard, T. D., Pandharipande, P. P. & Ely, E. W. Delirium in the intensive care unit. Crit. Care 3 (SUPPL. 3), S3 (2008).
87. Figueroa-Ramos, M. I., Arroyo-Novoa, C. M., Lee, K. A., Padilla, G. & Puntillo, K. A. Sleep and delirium in ICU patients: A review of mechanisms and manifestations. Intensive Care Med. 35, 781-795 (2009).
88. Campbell, N. et al. The cognitive impact of anticholinergics: A clinical review. Clin. Interv. Aging 4, 225-233 (2009).
89. Sprung, C. L. et al. Amino acid alterations and encephalopathy in the sepsis syndrome. Crit. Care Med. 19, 753-757 (1991).
90. Kadoi, Y. & Saito, S. An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit. Care Med. 24, 298-305 (1996).
91. Pascual, B. et al. Decreased carbon-11-flumazenil binding in early alzheimer?s disease. Brain 135, 2817-2825 (2012).
92. Nikolaus, S. et al. Pharmacological challenge and synaptic response-assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Rev. Neurosci. 22, 625-645 (2011).
93. Pavese, N. & Brooks, D. J. Imaging neurodegeneration in Parkinson?s disease. Biochim. Biophys. Acta 1792, 722-729 (2009).
94. Walker, Z. & Rodda, J. Dopaminergic imaging: Clinical utility now and in the future. Int. Psychogeriatr. 2 (SUPPL. 2), S32-S40 (2011).
95. Horti, A. & Wong, D. Radioligands for imaging cerebral nicotinic acetylcholine. PET Clin. 4, 89-100 (2009).
96. Zubieta, J. K., Koeppe, R. A., Mulholland, G. K., Kuhl, D. E. & Frey, K. A. Quantification of muscarinic cholinergic receptors with development and differentiation of tracer delivery from receptor binding. J. Cereb. Blood Flow Metab. 18, 619-631 (1998).
97. Gründer, G. et al. [18F]Fluoroethylflumazenil: A novel tracer for PET imaging of human benzodiazepine receptors. Eur. J. Nucl. Med. 28, 1463-1470 (2001).
98. van Gool, W. A, van De Beek, D. & Eikelenboom, P. Systemic infection and delirium: When cytokines and acetylcholine collide. Lancet 375, 773-775 (2010).
99. Monti, M. M. et al. Willful modulation of brain activity in disorders of consciousness. N. Engl. J. Med. 362, 579-589 (2010).
100. Kasahara, M. et al. Altered functional connectivity in the motor network after traumatic brain injury. Neurology 75, 168-176 (2010).
101. Boly, M. et al. Intrinsic brain activity in altered states of consciousness: How conscious is the default mode of brain function? Ann. NY Acad. Sci. 1129, 119-129 (2008).
102. Stamatakis, E. A, Adapa, R. M., Absalom, A. R. & Menon, D. K. Changes in resting neural connectivity during propofol sedation. PLoS ONE 5, e14224 (2010).
103. Hattori, N. et al. Acute changes in regional cerebral 18F-FDG kinetics in patients with traumatic brain injury. J. Nucl. Med. 45, 775-783 (2004).